792 related articles for article (PubMed ID: 1316611)
1. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
[TBL] [Abstract][Full Text] [Related]
2. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P
Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
[TBL] [Abstract][Full Text] [Related]
3. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex.
Arroyo M; Bagchi S; Raychaudhuri P
Mol Cell Biol; 1993 Oct; 13(10):6537-46. PubMed ID: 8413252
[TBL] [Abstract][Full Text] [Related]
4. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
Dick FA; Sailhamer E; Dyson NJ
Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
[TBL] [Abstract][Full Text] [Related]
6. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.
Hiebert SW; Chellappan SP; Horowitz JM; Nevins JR
Genes Dev; 1992 Feb; 6(2):177-85. PubMed ID: 1531329
[TBL] [Abstract][Full Text] [Related]
7. Novel mechanisms of E2F induction by BK virus large-T antigen: requirement of both the pRb-binding and the J domains.
Harris KF; Christensen JB; Radany EH; Imperiale MJ
Mol Cell Biol; 1998 Mar; 18(3):1746-56. PubMed ID: 9488491
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7.
Zerfass K; Levy LM; Cremonesi C; Ciccolini F; Jansen-Dürr P; Crawford L; Ralston R; Tommasino M
J Gen Virol; 1995 Jul; 76 ( Pt 7)():1815-20. PubMed ID: 9049387
[TBL] [Abstract][Full Text] [Related]
9. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
Fattaey AR; Harlow E; Helin K
Mol Cell Biol; 1993 Dec; 13(12):7267-77. PubMed ID: 8246949
[TBL] [Abstract][Full Text] [Related]
10. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein.
Wu EW; Clemens KE; Heck DV; Münger K
J Virol; 1993 Apr; 67(4):2402-7. PubMed ID: 8445736
[TBL] [Abstract][Full Text] [Related]
11. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation.
Zalvide J; DeCaprio JA
Mol Cell Biol; 1995 Oct; 15(10):5800-10. PubMed ID: 7565733
[TBL] [Abstract][Full Text] [Related]
12. The E2F transcription factor is a cellular target for the RB protein.
Chellappan SP; Hiebert S; Mudryj M; Horowitz JM; Nevins JR
Cell; 1991 Jun; 65(6):1053-61. PubMed ID: 1828392
[TBL] [Abstract][Full Text] [Related]
13. Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
Ikeda MA; Nevins JR
Mol Cell Biol; 1993 Nov; 13(11):7029-35. PubMed ID: 8413292
[TBL] [Abstract][Full Text] [Related]
14. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
[TBL] [Abstract][Full Text] [Related]
15. E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter.
Pützer BM; Rumpf H; Rega S; Brockmann D; Esche H
J Virol; 1997 Dec; 71(12):9538-48. PubMed ID: 9371617
[TBL] [Abstract][Full Text] [Related]
16. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
17. Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts.
Defeo-Jones D; Vuocolo GA; Haskell KM; Hanobik MG; Kiefer DM; McAvoy EM; Ivey-Hoyle M; Brandsma JL; Oliff A; Jones RE
J Virol; 1993 Feb; 67(2):716-25. PubMed ID: 8380462
[TBL] [Abstract][Full Text] [Related]
18. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes.
Mal A; Piotrkowski A; Harter ML
J Virol; 1996 May; 70(5):2911-21. PubMed ID: 8627766
[TBL] [Abstract][Full Text] [Related]
20. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression.
Hiebert SW
Mol Cell Biol; 1993 Jun; 13(6):3384-91. PubMed ID: 8497257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
